News from

Health & Medicine

Reset All Filters
187 Results
A mothers’ meetup like no other for families formed through uterus transplant
Two people embrace at a uterine transplant meetup lunch with a baby in a stroller and gifts on a conference table.

Image: Courtesy of Penn Medicine News

A mothers’ meetup like no other for families formed through uterus transplant

One week before Mother’s Day, those who gave birth through uterus transplant gathered for a special brunch with those who donated their uteruses for the procedure, and their respective families.

Alex Gardner

2 min. read

Promising inhibitor combination for hard-to-treat leukemia subtypes
Andres Blanco in a lab at Penn Vet.

Andrés Blanco is an assistant professor of biomedical science at Penn’s School of Veterinary Medicine.

(Image: John Donges)

Promising inhibitor combination for hard-to-treat leukemia subtypes

Researchers from Penn Vet and other institutions have identified a novel inhibitor combination of molecules that induce terminal differentiation for the treatment of human non-APL subtypes of AML.

From Penn Vet

2 min. read

Soon-to-be-graduate hopes to deliver primary care to rural communities
Chip Chambers stands on college campus.

nocred

Soon-to-be-graduate hopes to deliver primary care to rural communities

Fueled by his faith, Chip Chambers, a fifth-year M.D./M.B.A. student in the Perelman School of Medicine and Wharton School, has always looked for ways to serve.“My faith is a huge motivator of everything that I do. I just believe that I’ve been blessed with a lot of things that I didn’t earn and that I have a responsibility to steward those for the good of other people and not for myself,” Chambers says.

4 min. read

Enhanced CAR T cell therapy offers new strategy for lymphoma
3-D rendering of chimeric antigen receptor T (CAR-T) cell therapy, a treatment for a variety of cancers

Image: iStock/Naeblys

Enhanced CAR T cell therapy offers new strategy for lymphoma

A new study from Penn Medicine marks a significant development in the ongoing evolution of CAR T cell therapy, as a novel cytokine-enhanced CAR T that has been tested in patients with blood cancer shows robust response rates.

Meagan Raeke

2 min. read

First new subtype of Castleman disease discovered in 45 years
David Fajgenbaum in his lab.

David Fajgenbaum is an assistant professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and associate director of patient impact in the Penn Orphan Disease Center. He also leads the Castleman Disease Research Program.

(Image: Courtesy of Penn Medicine)

First new subtype of Castleman disease discovered in 45 years

A new study co-authored by Penn Medicine’s David Fajgenbaum expands the spectrum of the rare disorder, which will help diagnose and treat patients caught between existing classification systems.

2 min. read

Study suggests parents of preterm infants miss more postpartum care

Study suggests parents of preterm infants miss more postpartum care

Researchers from the Leonard Davis Institute have investigated whether the intensive focus on neonatal care for preterm infants may come at the expense of critical maternal follow-up, and recommend integrating maternal health care into the NICU.

From Penn LDI

2 min. read

Penn Dental Medicine renews MOU with Jagiellonian University Medical College

Penn Dental Medicine renews MOU with Jagiellonian University Medical College

The renewed MOU, signed by Penn Dental Medicine’s Morton Amsterdam Dean, Dr. Mark Wolff, and Penn Dental professor Uri Hangorsky, will further strengthen the partnership, facilitating joint research projects, faculty exchanges, and student programs.